Company: WHWK
Filing Date: 2025-01-21
Form Type: PREM14A
Source: 0001193125-25-009599
Chunk: 468

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-01-21
Form: PREM14A
Chunk 468
---
,698                                                                                                    
 shares of common stock held indirectly by the Anishka Irrevocable 2016 Trust dated October 19, 2016 (the “Anishka Irrevocable Trust”), and (iii) 455,450 shares of common stock issuable upon the exercise of |

- 315 -

| (9) | Consists of (i) 346,226 shares of common stock issuable upon the exercise of options within 60 days of                                                                                                    
 December 31, 2024 (ii); 7,500 shares issuable upon the vesting of restricted stock units within 60 days of December 31, 2024 and (iii) 3,000 shares of common stock held indirectly by Dr. Itri’s spouse. |

| (10) | Consists of (i) 19,694 shares of common stock held directly by Dr. Castelein, (ii) 499,998 shares of                                                                                                                              
 common stock held indirectly by KVP Capital, LP (“KVP Capital”), and (iii) 71,895 shares of common stock issuable upon the exercise of options within 60 days of December 31, 2024. Dr. Castelein is the Managing Director of KVP 
 Capital and Dr. Castelein disclaims beneficial ownership of the shares held by KVP Capital, except to the extent of his pecuniary interest therein.                                                                               |

| (11) | Consists of (i) the securities listed in footnote (1) above and (ii) 64,377 shares of common stock 
 issuable upon the exercise of options within 60 days of December 31, 2024.                         |

| (12) | Consists of (i) 1,130 shares of common stock held directly by Dr. Dalal; (ii) the securities listed                                       
 in footnote (2) above, and (iii) 71,895 shares of common stock issuable upon the exercise of options within 60 days of December 31, 2024. |

| (13) | Consists of 63,314 shares of common stock issuable upon the exercise of options within 60 days of 
 December 31, 2024.                                                                                |

| (14) | Consists of 37,826 shares of common stock issuable upon the exercise of options within 60 days of 
 December 31, 2024.                                                                                |

| (15) | Consists of 88,